D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 51 Citations 12,904 238 World Ranking 12445 National Ranking 15

Overview

What is he best known for?

The fields of study he is best known for:

  • Acquired immunodeficiency syndrome
  • Gene
  • Virus

Tulio de Oliveira mostly deals with Genetics, Demography, Acquired immunodeficiency syndrome, Virology and Genome. His Genetics study typically links adjacent topics like Genetic diversity. His Acquired immunodeficiency syndrome study combines topics in areas such as Transmission, Regimen, Logistic regression and Developing country.

His research in Virology intersects with topics in Antibody and Convalescent plasma, Coronavirus, Coronavirus disease 2019. His study in Genome is interdisciplinary in nature, drawing from both Genome-wide association study, Disease, Genetic association and Disease transmission. In his study, which falls under the umbrella issue of Young adult, Viral load is strongly linked to Cross-sectional study.

His most cited work include:

  • An automated genotyping system for analysis of HIV-1 and other microbial sequences (439 citations)
  • Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools. (198 citations)
  • Renewing Felsenstein’s phylogenetic bootstrap in the era of big data (185 citations)

What are the main themes of his work throughout his whole career to date?

Virology, Drug resistance, Viral load, Transmission and Genetics are his primary areas of study. The study incorporates disciplines such as Severe acute respiratory syndrome coronavirus 2, Coronavirus disease 2019 and Genotype in addition to Virology. His Drug resistance study integrates concerns from other disciplines, such as Regimen, Internal medicine, Cohort, HIV drug resistance and Efavirenz.

His Viral load study combines topics from a wide range of disciplines, such as Coinfection, Cross-sectional study and Intensive care medicine. In his papers, Tulio de Oliveira integrates diverse fields, such as Transmission and Demography. His research on Genome also deals with topics like

  • Disease transmission and Microbial genome most often made with reference to Genome-wide association study,
  • DNA sequencing, which have a strong connection to Computational biology.

He most often published in these fields:

  • Virology (33.16%)
  • Drug resistance (26.42%)
  • Viral load (26.94%)

What were the highlights of his more recent work (between 2019-2021)?

  • Severe acute respiratory syndrome coronavirus 2 (12.44%)
  • Coronavirus disease 2019 (9.33%)
  • Virology (33.16%)

In recent papers he was focusing on the following fields of study:

His main research concerns Severe acute respiratory syndrome coronavirus 2, Coronavirus disease 2019, Virology, Pandemic and 2019-20 coronavirus outbreak. Tulio de Oliveira works mostly in the field of Coronavirus disease 2019, limiting it down to topics relating to Transmission and, in certain cases, Zika virus and Treatment outcome, as a part of the same area of interest. Tulio de Oliveira is studying Virus, which is a component of Virology.

Tulio de Oliveira has included themes like Epidemiology, Phylogenetics, Lineage, Outbreak and Whole genome sequencing in his Pandemic study. His research on Phylogenetics concerns the broader Genetics. His Outbreak research includes elements of Genotyping and Molecular epidemiology.

Between 2019 and 2021, his most popular works were:

  • SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma. (177 citations)
  • SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma (82 citations)
  • Sixteen novel lineages of SARS-CoV-2 in South Africa. (59 citations)

In his most recent research, the most cited papers focused on:

  • Acquired immunodeficiency syndrome
  • Gene
  • Virus

Tulio de Oliveira mainly focuses on Severe acute respiratory syndrome coronavirus 2, Pandemic, Coronavirus disease 2019, Coronavirus and Outbreak. Tulio de Oliveira combines subjects such as Environmental health, Regimen, Clinical endpoint, Randomized controlled trial and Adverse effect with his study of Severe acute respiratory syndrome coronavirus 2. His Pandemic research integrates issues from Epidemiology, Phylogenetics, Lineage, Whole genome sequencing and Genomics.

Tulio de Oliveira works mostly in the field of Epidemiology, limiting it down to topics relating to Molecular epidemiology and, in certain cases, Phylogenetic tree. The concepts of his Coronavirus disease 2019 study are interwoven with issues in Placebo, 2019-20 coronavirus outbreak, Incidence and Virology. Tulio de Oliveira interconnects Lineage, Antibody and Convalescent plasma in the investigation of issues within Virology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Detection of a SARS-CoV-2 variant of concern in South Africa.

Houriiyah Tegally;Eduan Wilkinson;Marta Giovanetti;Marta Giovanetti;Arash Iranzadeh.
Nature (2021)

976 Citations

SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma.

Constantinos Kurt Wibmer;Frances Ayres;Tandile Hermanus;Mashudu Madzivhandila.
Nature Medicine (2021)

897 Citations

Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa

Houriiyah Tegally;Eduan Wilkinson;Marta Giovanetti;Marta Giovanetti;Arash Iranzadeh.
medRxiv (2020)

857 Citations

An automated genotyping system for analysis of HIV-1 and other microbial sequences

Tulio De Oliveira;Koen Deforche;Sharon Cassol;Mika Salminen.
Bioinformatics (2005)

564 Citations

Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma.

Sandile Cele;Inbal Gazy;Inbal Gazy;Laurelle Jackson;Shi-Hsia Hwa.
Nature (2021)

505 Citations

New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications.

Salim S Abdool Karim;Tulio de Oliveira.
The New England Journal of Medicine (2021)

491 Citations

Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant.

Vivek Shinde;Sutika Bhikha;Zaheer Hoosain;Moherndran Archary.
The New England Journal of Medicine (2021)

382 Citations

HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis

Ravindra K Gupta;John Gregson;Neil Parkin;Hiwot Haile-Selassie.
Lancet Infectious Diseases (2017)

332 Citations

Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools.

Andrea Clemencia Pineda-Peña;Andrea Clemencia Pineda-Peña;Nuno Rodrigues Faria;Stijn Imbrechts;Pieter Libin.
Infection, Genetics and Evolution (2013)

310 Citations

Sixteen novel lineages of SARS-CoV-2 in South Africa.

Houriiyah Tegally;Eduan Wilkinson;Richard J. Lessells;Jennifer Giandhari.
Nature Medicine (2021)

267 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Tulio de Oliveira

Anne-Mieke Vandamme

Anne-Mieke Vandamme

Rega Institute for Medical Research

Publications: 101

Oliver G. Pybus

Oliver G. Pybus

University of Oxford

Publications: 59

Deenan Pillay

Deenan Pillay

University College London

Publications: 55

Nuno Rodrigues Faria

Nuno Rodrigues Faria

Imperial College London

Publications: 54

Jesse D. Bloom

Jesse D. Bloom

Fred Hutchinson Cancer Research Center

Publications: 53

Kristel Van Laethem

Kristel Van Laethem

Rega Institute for Medical Research

Publications: 53

Massimo Ciccozzi

Massimo Ciccozzi

Università Campus Bio-Medico

Publications: 45

Pontiano Kaleebu

Pontiano Kaleebu

London School of Hygiene & Tropical Medicine

Publications: 44

Amilcar Tanuri

Amilcar Tanuri

Federal University of Rio de Janeiro

Publications: 44

Till Bärnighausen

Till Bärnighausen

Heidelberg University

Publications: 42

Paul D. Bieniasz

Paul D. Bieniasz

Rockefeller University

Publications: 41

Robert W. Shafer

Robert W. Shafer

Stanford University

Publications: 38

Michel C. Nussenzweig

Michel C. Nussenzweig

Rockefeller University

Publications: 38

Davey M. Smith

Davey M. Smith

University of California, San Diego

Publications: 38

Marco Salemi

Marco Salemi

University of Florida

Publications: 37

Philippe Lemey

Philippe Lemey

KU Leuven

Publications: 36

Trending Scientists

Thierry Coulhon

Thierry Coulhon

PSL University

Jeffrey Farr

Jeffrey Farr

Nielsen (United States)

James H. Anderson

James H. Anderson

University of North Carolina at Chapel Hill

Satwinder Malhi

Satwinder Malhi

Texas Instruments (United States)

Kaido Tammeveski

Kaido Tammeveski

University of Tartu

Pan Ming Huang

Pan Ming Huang

University of Saskatchewan

Yiyu Feng

Yiyu Feng

Tianjin University

Paul Meredith

Paul Meredith

Swansea University

Robert B. Trumbull

Robert B. Trumbull

University of Potsdam

Richard A. Stern

Richard A. Stern

University of Alberta

Paul Morgan

Paul Morgan

Colorado School of Mines

Bernd Weber

Bernd Weber

University of Bonn

Rui Appelberg

Rui Appelberg

University of Porto

Michael Rufer

Michael Rufer

University of Zurich

Reuven Dar

Reuven Dar

Tel Aviv University

Kimberly A. Yonkers

Kimberly A. Yonkers

Yale University

Something went wrong. Please try again later.